诺和诺德公司下调业绩指引并CEO辞职被视为"双重意外":BMO

英为财情
Jul 29, 2025

Investing.com -- 据BMO Capital Markets分析师Evan David Seigerman表示,诺和诺德公司下调业绩指引和CEO辞职代表了一个"双重意外"。 在给客户的一份报告中,保持对这家丹麦制药商"市场表现"评级的Seigerman指出了影响公司业绩的"多方面阻力"。 该分析师强调,诺和诺德公司在美国市场的关键产品——减肥药Wegovy和糖尿病药物Ozempic的...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10